 |
 |
|
 |
July 1, 2008 : |
Intellectual Property Report was updated |
|
June 30, 2008 : |
Results of the US Phase II clinical trial (“HGF-STAT Trial”) were published in Circulation |
|
May 26, 2008 : |
Medical Use Patent for the Combination Use of HGF and PGIS
Granted in Europe - Covering Angiogenic Therapy - |
|
May 15, 2008 : |
New Medical-Use Patent for HGF Gene Granted in Europe
- Covering Cardiomyopathy - |
|
April 14, 2008 : |
AnGes MG, Inc. Launched Naglazyme in Japan |
|
April 7, 2008 : |
Medical Use Patent on NF-κB Decoy-Oligo Granted in Europe - Covering Its Use for Atopic Dermatitis |
|
March 28, 2008 : |
AnGes Submits NDA for HGF Gene Therapy |
|
March 28, 2008 : |
AnGes MG, Inc. Receives Approval for Manufacturing and Marketing of Naglazyme |
|
February 25, 2008 : |
Status Updates of NDA application of Naglazyme for the Treatment of Mucopolysaccharidosis VI |
|
February 12, 2008 : |
Supplemental Announcement of Results of Phase II Clinical Trials of NF-κB Decoy Oligodeoxinucleotides on Atopic Dermatitis |
|
February 8, 2008 : |
Announcement of Results of Phase II Clinical Trials of
NF-κB Decoy Oligodeoxynucleotide on Atopic Dermatitis |
| |
|
|
|
